Baltimore Community Meeting
VirtualTargeting GLP-1 to Slow PKD Progression
7:00 pm - 8:00 pm
7:00 pm - 8:00 pm
Join us for a discussion with Dr. Paul Grimm, Pediatric Nephrologist at Stanford Medicine Children’s, to learn about the DISOT Study at Stanford.
Join us for a discussion with Dr. Paul Grimm, Pediatric Nephrologist at Stanford Medicine Children’s, to learn about the DISOT Study at Stanford. The DISOT (dual immune/solid organ transplant) study provides children with both stem cells and a kidney from the same donor—often a parent. This innovative approach allows the child to develop a new immune system that recognizes the kidney, enabling the body to accept the transplant without the need for long-term immunosuppressive medications. Please note: this study is not yet used for PKD.
Targeting GLP-1 to Slow PKD Progression
Targeting GLP-1 to Slow PKD Progression
Exploring Living Donation: An Introduction to the National Kidney Registry
Serving the PKD Community Across Wisconsin
Welcome Back! San Francisco Community Kickoff